Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

about

Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System.cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging.

P2860

Q52809588-75BEA597-73C9-4641-A350-14526EE20F7B Q54978990-AC4269AD-0208-4D8D-9C31-B4BDB8E80858 Q55004774-875AFEE5-D1FF-4D01-9798-12744D5D2928

P2860

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

Item

http://www.wikidata.org/entity/Q38992600

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

@en

type

Item

label

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

@en

prefLabel

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

@en

P1476

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

@en

P2093

David A Kass

http://www.w3.org/2001/XMLSchema#string

Grace E Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cells

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder

Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase

Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes

P304

249-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_82

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27787716

http://www.w3.org/2001/XMLSchema#string

P932

5665023

http://www.w3.org/2001/XMLSchema#string

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

about

P2860

P2860

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932